BNP Paribas Financial Markets’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-15
| Closed | -$55 | – | 5913 |
|
|
2026
Q1 | $55 | Hold |
15
| – | – | ﹤0.01% | 5720 |
|
|
2025
Q4 | $52 | Hold |
15
| – | – | ﹤0.01% | 5642 |
|
|
2025
Q3 | $32 | Hold |
15
| – | – | ﹤0.01% | 5485 |
|
|
2025
Q2 | $34 | Hold |
15
| – | – | ﹤0.01% | 5372 |
|
|
2025
Q1 | $21 | Hold |
15
| – | – | ﹤0.01% | 5320 |
|
|
2024
Q4 | $24 | Hold |
15
| – | – | ﹤0.01% | 5343 |
|
|
2024
Q3 | $19 | Hold |
15
| – | – | ﹤0.01% | 4106 |
|
|
2024
Q2 | $20 | Hold |
15
| – | – | ﹤0.01% | 4005 |
|
|
2024
Q1 | $20 | Hold |
15
| – | – | ﹤0.01% | 4000 |
|
|
2023
Q4 | $39 | Hold |
15
| – | – | ﹤0.01% | 3970 |
|
|
2023
Q3 | $48 | Buy |
+15
| New | +$70 | ﹤0.01% | 3869 |
|
|
2023
Q1 | – | Sell |
-48
| Closed | -$112 | – | 3857 |
|
|
2022
Q4 | $112 | Sell |
48
-5,052
| -99% | -$15.4K | ﹤0.01% | 3953 |
|
|
2022
Q3 | $22.9K | Buy |
5,100
+2,652
| +108% | +$19K | ﹤0.01% | 4090 |
|
|
2022
Q2 | $14.3K | Sell |
2,448
-1,762
| -42% | -$9.04K | ﹤0.01% | 3721 |
|
|
2022
Q1 | $27.5K | Sell |
4,210
-2,117
| -33% | -$20.9K | ﹤0.01% | 3677 |
|
|
2021
Q4 | $81.1K | Buy |
6,327
+882
| +16% | +$12.3K | ﹤0.01% | 3651 |
|
|
2021
Q3 | $75.4K | Buy |
5,445
+4,048
| +290% | +$42.6K | ﹤0.01% | 3389 |
|
|
2021
Q2 | $14.4K | Sell |
1,397
-11,665
| -89% | -$116K | ﹤0.01% | 3626 |
|
|
2021
Q1 | $126K | Buy |
13,062
+5,949
| +84% | +$59.5K | ﹤0.01% | 3244 |
|
|
2020
Q4 | $51.2K | Sell |
7,113
-1,088
| -13% | -$7.21K | ﹤0.01% | 3546 |
|
|
2020
Q3 | $38.6K | Buy |
8,201
+6,401
| +356% | +$31.7K | ﹤0.01% | 3586 |
|
|
2020
Q2 | $9.99K | Sell |
1,800
-8,446
| -82% | -$35.1K | ﹤0.01% | 3709 |
|
|
2020
Q1 | $36.8K | Buy |
10,246
+2,733
| +36% | +$18.3K | ﹤0.01% | 3691 |
|
|
2019
Q4 | $63.6K | Buy |
7,513
+3,306
| +79% | +$23.9K | ﹤0.01% | 3515 |
|
|
2019
Q3 | $28.5K | Buy |
4,207
+2,798
| +199% | +$19.9K | ﹤0.01% | 3782 |
|
|
2019
Q2 | $9.47K | Buy |
+1,409
| New | +$7.66K | ﹤0.01% | 4110 |
|
|
2015
Q3 | – | Sell |
-2
| Closed | -$6 | – | 3619 |
|
|
2015
Q2 | $6 | Hold |
2
| – | – | ﹤0.01% | 3531 |
|
|
2015
Q1 | $5 | Hold |
2
| – | – | ﹤0.01% | 3604 |
|
|
2014
Q4 | $7 | Hold |
2
| – | – | ﹤0.01% | 1965 |
|
|
2014
Q3 | $8 | Sell |
2
-24
| -92% | -$97 | ﹤0.01% | 4076 |
|
|
2014
Q2 | $94 | Hold |
26
| – | – | ﹤0.01% | 3759 |
|
|
2014
Q1 | $103 | Hold |
26
| – | – | ﹤0.01% | 3296 |
|
|
2013
Q4 | $55 | Buy |
+26
| New | +$63 | ﹤0.01% | 4081 |
|
Other funds holding APYX
VCM
ACM
SBCM
HKAM
TFCM
LCM
BNP Paribas Financial Markets's APYX Position: Q2 2026 in Review
BNP Paribas Financial Markets sold out of Apyx Medical (APYX) in Q2 2026, closing a stake of 15 shares — an estimated $55 sold.
BNP Paribas Financial Markets first reported a position in APYX in Q4 2013 and held it in 33 quarters. The position peaked at $126K in Q1 2021. 46 funds tracked by Wall St. Rank hold APYX as of Q2 2026.
- BNP Paribas Financial Markets reported no remaining Apyx Medical position as of Q2 2026 after selling out during the quarter.
- BNP Paribas Financial Markets sold 15 Apyx Medical shares in Q2 2026, an estimated $55.
- BNP Paribas Financial Markets first reported a position in Apyx Medical in Q4 2013 and held it in 33 quarters.
- BNP Paribas Financial Markets's Apyx Medical position peaked at $126K in Q1 2021.
- 46 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.